Trials
Search / Trial NCT05655845

Risk Factors for Bowel Dysfunction at Preschool and Early Childhood Age in Children With Hirschsprung Disease

Launched by WEIBING TANG · Dec 9, 2022

Trial Information

Current as of January 13, 2025

Recruiting

Keywords

Hirschsprung Disease Bowel Function Associated Factors

ClinConnect Summary

This clinical trial is looking at the risk factors that can lead to bowel problems in young children who have had surgery for Hirschsprung disease, a condition that affects how the intestines work. Bowel dysfunction, which includes issues like constipation and incontinence, is a common problem for these children and can continue into adulthood, affecting their social lives and overall well-being. The goal of this study is to better understand why some children experience these issues after their surgery so that healthcare providers can offer better support and treatment.

To participate in this trial, children need to have a confirmed diagnosis of Hirschsprung disease and should have completed toilet training. However, children who have had a redo surgery for Hirschsprung disease or have other conditions like Down syndrome that might affect their bowel function are not eligible. If your child participates, they will help researchers identify important factors related to bowel health, which could lead to better outcomes for children with this condition in the future. The study is currently recruiting participants, so if you think your child may qualify, it could be a great opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Clinical dignosis with Hirschsprung disease
  • 2. completed the toilet training
  • Exclusion Criteria:
  • 1. redo-pull-through,
  • 2. Down syndrome or other co-morbidities that impaired functional outcomes

Trial Officials

Weibing Tang, Dr

Study Director

Children's Hospital of Nanjing Medical University

About Weibing Tang

Weibing Tang is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a robust network of clinical sites and a team of experienced professionals, Weibing Tang ensures compliance with regulatory standards while prioritizing patient safety and data integrity. The sponsor is driven by a mission to facilitate the development of transformative therapies that address unmet medical needs, ultimately contributing to the improvement of global health.

Locations

Nanjing, Jiangsu, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials